MR imaging in the evaluation of isolated limb perfusion:: a prospective study of 18 cases

被引:16
作者
Vanel, D
Bonvalot, S
Guinebretière, JM
Petrow, P
Dromain, C
Caillet, H
机构
[1] Inst Gustave Roussy, Dept Radiol, F-94805 Villejuif, France
[2] Inst Gustave Roussy, Dept Surg, F-94805 Villejuif, France
[3] Ctr Rene Huguenin, Dept Pathol, F-92210 St Cloud, France
关键词
soft tissues; neoplasms; magnetic resonance (MR); chemotherapy; isolated limb perfusion;
D O I
10.1007/s00256-003-0726-x
中图分类号
R826.8 [整形外科学]; R782.2 [口腔颌面部整形外科学]; R726.2 [小儿整形外科学]; R62 [整形外科学(修复外科学)];
学科分类号
摘要
Purpose. To prospectively evaluate the use of MRI with dynamic sequences during isolated limb perfusion (ILP) for soft tissue sarcomas, an aggressive local treatment using very high-dose chemotherapy and tumor necrosis factor aimed at avoiding limb amputation. Design and patients. Twenty-six patients were referred for ILP over one and a half years; eight were excluded as the lesions were either too proximal or suspicious inflammatory changes without tumor were found on the initial MRI, or the vascular status was poor. The indications for ILP were: vessel nerve involvement (13), multiple lesions (8), tumor size (4) or the presence of pulmonary metastases (2). MRI was performed 1 and 2 months after ILP, immediately prior to surgery and histological analysis. The MR examinations included T1-weighted SE and fast SE T2-weighted fat-saturated sequences, as well as dynamic sequences (T1-weighted SE repeated six times every 40 s), displaying the maximum intensity slope in each pixel. Results. The tumor had disappeared in three patients. One patient still had histologically proven isolated widespread tumor cells without a mass. The tumor size had increased in two patients. In six patients, the size of the tumor had not changed but it had become completely necrotic, with a thin wall.In three patients, after an initially good result MRI demonstrated that the tumor wall had become thickened from 1 to 2 months after ILP. Dynamic MRI was mainly useful during the initial examination, demonstrating two patients with inflammatory changes without tumor. Three amputations and a second ILP were proposed based on poor results. Conservative limb-sparing surgery was successful in the other cases. Conclusion. MRI proved valuable in demonstrating the variable responses to ILP.
引用
收藏
页码:150 / 156
页数:7
相关论文
共 15 条
[1]   Isolated limb perfusion with tumour necrosis factor-α and melphalan for unresectable bone sarcomas of the lower extremity [J].
Bickels, J ;
Manusama, ER ;
Gutman, M ;
Eggermont, AMM ;
Kollender, Y ;
Abu-Abid, S ;
Van Geel, AN ;
Lev-Shlush, D ;
Klausner, JM ;
Meller, I .
EUROPEAN JOURNAL OF SURGICAL ONCOLOGY, 1999, 25 (05) :509-514
[2]   OSTEOSARCOMA AFTER CHEMOTHERAPY - EVALUATION WITH CONTRAST MATERIAL ENHANCED SUBTRACTION MR IMAGING [J].
DEBAERE, T ;
VANEL, D ;
SHAPEERO, LG ;
CHARPENTIER, A ;
TERRIER, P ;
DIPAOLA, M .
RADIOLOGY, 1992, 185 (02) :587-592
[3]   STATISTICAL-ANALYSIS OF MRI PARAMETERS PREDICTING MALIGNANCY IN 141 SOFT-TISSUE MASSES [J].
DESCHEPPER, AM ;
RAMON, FA ;
DEGRYSE, HR .
FORTSCHRITTE AUF DEM GEBIETE DER RONTGENSTRAHLEN UND DER NEUEN BILDGEBENDEN VERFAHREN, 1992, 156 (06) :587-591
[4]   Isolated limb perfusion for extremity soft-tissue sarcomas, in-transit metastases, and other unresectable tumors: credits, debits, and future perspectives. [J].
Eggermont A.M. ;
ten Hagen T.L. .
Current Oncology Reports, 2001, 3 (4) :359-367
[5]   Isolated limb perfusion with tumor necrosis factor and melphalan for limb salvage in 186 patients with locally advanced soft tissue extremity sarcomas - The cumulative multicenter European experience [J].
Eggermont, AMM ;
Koops, HS ;
Klausner, JM ;
Kroon, BBR ;
Schlag, PM ;
Lienard, D ;
vanGeel, AN ;
Hoekstra, HJ ;
Meller, I ;
Nieweg, OE ;
Kettelhack, C ;
BenAri, G ;
Pector, JC ;
Lejeune, FJ .
ANNALS OF SURGERY, 1996, 224 (06) :756-765
[6]   Isolated limb perfusion with high-dose tumor necrosis factor-alpha in combination with interferon-gamma and melphalan for nonresectable extremity soft tissue sarcomas: A multicenter trial [J].
Eggermont, AMM ;
Koops, HS ;
Lienard, D ;
Kroon, BBR ;
vanGeel, AN ;
Hoekstra, HJ ;
Lejeune, FJ .
JOURNAL OF CLINICAL ONCOLOGY, 1996, 14 (10) :2653-2665
[7]   DYNAMIC, GADOLINIUM-ENHANCED MR IMAGING TO MONITOR TUMOR RESPONSE TO CHEMOTHERAPY [J].
ERLEMANN, R .
RADIOLOGY, 1993, 186 (03) :904-904
[8]  
Lejeune F J, 2001, Surg Oncol Clin N Am, V10, P821
[9]  
Lev-Chelouche D, 1999, J SURG ONCOL, V70, P185, DOI 10.1002/(SICI)1096-9098(199903)70:3<185::AID-JSO8>3.0.CO
[10]  
2-#